Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,042.00
(
-1.03%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.60
(
1.35%
)
Bitcoin
68,410.02
(
0.84%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bladerunner1717 post# 125694

Wednesday, 08/31/2011 9:17:31 AM

Wednesday, August 31, 2011 9:17:31 AM

Post# of 257269
Medivir completes patient enrollment in QUEST-1, QUEST-2, and PROMISE phase-3 trials for TMC435:

http://finance.yahoo.com/news/Medivir-Completed-Enrollment-bw-530378270.html?x=0&.v=1

Each trial has 375 patients and uses a response-guided duration of treatment.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today